Drug intelligence / Profile preview

paracetamol + metamizole + ketorolac

Development stage
Unknown
Lead developer
Hospital General Naval de Alta Especialidad - Escuela Médico Naval
Modality
Small Molecules
Administration
Oral, Intravenous
01

Overview

This entry refers to the specific analgesic regimen used as the control arm in a clinical trial (NCT02684305) conducted by the Hospital General Naval de Alta Especialidad - Escuela Medico Naval. The regimen consists of a combination of three non-opioid analgesics: paracetamol (acetaminophen), metamizole (dipyrone), and ketorolac. Paracetamol and metamizole are primarily used for their analgesic and antipyretic properties, while ketorolac is a potent non-steroidal anti-inflammatory drug (NSAID) that provides significant postoperative pain relief. The combination works by inhibiting cyclooxygenase (COX) enzymes, thereby reducing the synthesis of pro-inflammatory prostaglandins. This specific protocol was evaluated in pediatric patients aged 6 to 14 years undergoing surgery to compare its efficacy against laughter therapy in reducing postoperative pain, anxiety, and hospital stay duration.

Other names
Conventional treatment-Hospital General Naval de Alta Especialidad - Escuela Medico NavalConventional treatment
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on paracetamol + metamizole + ketorolac.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on paracetamol + metamizole + ketorolac.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call